Published in Pharma Law Weekly, September 27th, 2005
Evidence abounds - they win more than 70 percent of patent infringement cases settled in the courts, according to a report, "Combating Generics: Pharmaceutical Brand Defense," from pharmaceutical business intelligence firm Cutting Edge Information.
They are also winning in cases settled outside the courts. Authorized generics is a strategy pursued by branded pharmaceuticals whereby a brand manufacturer gives permission to one generic manufacturer - usually as part of a patent infringement lawsuit settlement - to distribute a generic copy of a drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly